TP53 and cancer: For PERCI AI, the algorithm selected genomic alterations in ERS1,FGFR2, and TP53, key cancer driver genes that were enriched in AI nonresponders, while PERCI TAM was based on a higher mutation frequency of ABCA13 in TAM responders.